Pulmonary bovine-type tuberculosis in rabbits: Bacillary virulence, inhaled dose effects, tuberculin sensitivity, and Mycobacterium vaccae immunotherapy

Clinical and Diagnostic Laboratory Immunology

Volumn 5, Issue 6, 1998, Pages 871-881

  Converse, P J ^a,f   Dannenberg Jr , A M ^a,b,f   Shigenaga, T ^a,f,g   Mcmurray, D N ^c   Phalen, S W ^c   Stanford, J L ^d   Rook, G A W ^d   Koru Sengul, T ^a,f   Abbey, Helen ^a,f   Estep, J E ^e   Pitt, M L M ^e  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TEXAS A AND M UNIVERSITY   (United States)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^f JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^g OITA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MYCOBACTERIUM ANTIGEN; TUBERCULIN;

ANIMAL DISEASE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DESENSITIZATION; DIAGNOSTIC ACCURACY; HOST RESISTANCE; IMMUNE RESPONSE; IMMUNOTHERAPY; INHALATION; LUNG TUBERCULOSIS; MYCOBACTERIUM VACCAE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SPECIES DIFFERENCE; VIRULENCE;

EID: 0031797986     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.5.6.871-881.1998     Document Type: Article

References (61)

1. Allison, M. J., P. Zappasodi, and M. B. Lurie. 1962. Host-parasite relationships in natively resistant and susceptible rabbits on quantitative inhalation of tubercle bacilli. Am. Rev. Respir. Dis. 85:553-569.
2. Bahr, G. M., J. L. Stanford, G. A. W. Rook, R. J. W. Rees, G. J. Frayha, and A. M. Abdelnoor. 1986. Two potential improvements to BCG and their effect on skin test reactivity in Lebanon. Tubercle 67:205-218.
3. Bartholomew, J. W. 1981. Stains for microorganisms in sections, p. 446-447. In H. J. Conn, M. A. Darrow, and V. M. Emmel (ed.), Staining procedures, 2nd ed. Williams & Wilkins, Baltimore, Md.
4. Bottasso, O., V. Merlin, L. Cannon, H. Cannon, N. Ingledew, M. Keni, R. Hartopp, C. Stanford, and J. Stanford. 1998. Studies of vaccination of persons in dose contact with leprosy patients in Argentina. Vaccine 16:1166-1171.
5. Bretscher, P. A., G. Wei, J. N. Menon, and H. Bielefeldt-Ohmann. 1992. Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. Science 257:539-542.
6. Catalog of the Mycobacterial Culture Collection. 1980. National Institutes of Health publication 80-289. National Institutes of Health, Bethesda, Md.
7. Collins, F. M., and M. M. Smith. 1969. A comparative study of the virulence of Mycobacterium tuberculosis measured in mice and guinea pigs. Am. Rev. Respir. Dis. 100:631-639.
8. Converse, P. J., A. M. Dannenberg, Jr., J. E. Estep, K. Sugisaki, Y. Abe, B. H. Schofield, and M. L. M. Pitt. 1996. Cavitary tuberculosis produced in rabbits by aerosolized virulent tubercle bacilli. Infect. Immun. 64:4776-4787.
9. Comstock, G., W. Personal communication.
10. Corlan, E. C. Marica, C. Macavei, J. L. Stanford, and C. A. Stanford. 1997. Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis in Romania. 2. Chronic or relapsed disease. Respir. Med. 91:21-29.
11. Dannenberg, A. M., Jr. 1991. Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosis. Immunol. Today 12:228-233.
12. Dannenberg, A. M., Jr. 1993. Immunopathogenesis of pulmonary tuberculosis. Hosp. Pract. 28:33-40, 51-58.
13. Dannenberg, A. M., Jr. 1994. Rabbit model of tuberculosis, p. 149-156. In B. R. Bloom (ed.) Tuberculosis: pathogenesis, protection, and control. American Society for Microbiology, Washington, D.C.
14. Dannenberg, A. M., Jr. 1998. Lurie's tubercle-count method to test TB vaccine efficacy in rabbits. Front. Biosci. 3:c27-33.
15. Dannenberg, A. M., Jr., M. Ando, and K. Shima. 1972. Macrophage accumulation, division, maturation, and digestive and microbial capacities in tuberculous lesions. III. The turnover of macrophages and its relation to their activation and antimicrobial immunity in primary BCG lesions and those of reinfection. J. Immunol. 109:1109-1121.
16. Dannenherg, A. M., Jr., M. S. Burstone, P. C. Walter, and J. W. Kinsley. 1963. A histochemical study of phagocytic and enzymatic functions of rabbit mononuclear and polymorphonuclear exudate cells and alveolar macrophages. I. Survey and quantitation of enzymes, and states of cellular activation. J. Cell Biol. 17:465-486.
17. Dannenherg, A. M., Jr., and G. A. W. Rook. 1994. Pathogenesis of pulmonary tuberculosis: an interplay of tissue-damaging and macrophage-activating immune responses - dual mechanisms that control bacillary multiplication, p. 459-483. In B. R. Bloom (ed.), Tuberculosis: pathogenesis, protection, and control. American Society for Microbiology, Washington, D.C.
18. Dannenberg, A. M., Jr., and M. Sugimoto. 1976. Liquefaction of caseous foci in tuberculosis. Am. Rev. Respir. Dis. 113:257-259.
19. Dannenberg, A. M., Jr., and J. F. Tomashefski, Jr. 1997. Pathogenesis of pulmonary tuberculosis, p. 2447-2471. In A. P. Fishman et al. (ed.), Fishman's pulmonary diseases and disorders, 3rd ed., vol. 2. McGraw-Hill Co., Inc., New York, N.Y.
20. Dannenberg, A. M., Jr., P. C. Walter, and F. A. Kapral. 1963. A histochemical study of phagocytic and enzymatic functions of rabbit mononuclear and polymorphonuclear exudate cells and alveolar macrophages. II. The effect of particle ingestion on enzyme activity; two phases of in vitro activation. J. Immunol. 90:448-465.
21. Daynes, R. A., B. A. Araneo, T. A. Dowell, K. Hung, and D. Dudley. 1990. Regulation of murine lymphokine production in vivo. III. The lymphoid tissue microenvironment exerts regulatory influences over T helper cell function. J. Exp. Med. 171:979-996.
22. Ellner, J. J. 1996. Immunosuppression in tuberculosis. Infect. Agents Dis. 5:62-72.
23. Ellner, J. J. 1997. Regulation of the human immune response during tuberculosis. J. Lab. Clin. Med. 130:469-475.
24. Ellner, J. J. 1997. Review: the immune response in human tuberculosis -implications for tuberculosis control. J. Infect. Dis. 176:1351-1959.
25. Fearon, D. T., and R. M. Locksley. 1996. The instructive role of innate immunity in the acquired immune response. Science 272:50-54.
26. Hernandez-Pando, R., and G. A. W. Rook. 1994. The role of TNF-alpha in T-cell-mediated inflammation depends upon the Th1/Th2 cytokine balance. Immunology 82:591-595.
27. Koch, R. 1890. Weitere Mittheilungen über ein Heilmittel gegen Tuberkulose. Dtsch. Med. Wochenschr. 16:1029-1032.
28. Lurie, M. B. 1964. Resistance to tuberculosis: experimental studies in native and acquired defensive mechanisms. Harvard University Press, Cambridge, Mass.
29. Lurie, M. B. Personal communication.
30. Lurie, M. B., A. G. Heppleston, S. Abramson, and I. B. Swartz. 1950. An evaluation of the method of quantitative airborne infection and its use in the study of the pathogenesis of tuberculosis. Am. Rev. Tuberc. 61:765-797.
31. Lurie, M. B., P. Zappasodi, E. Cardona-Lynch, and A. M. Dannenherg, Jr. 1952. The response to the intracutaneous inoculation of BCG as an index of native resistance to tuberculosis. J. Immunol. 68:369-387.
32. Lurie, M. B., P. Zappasodi, A. M. Dannenberg, Jr., and I. B. Swartz. 1951. Constitutional factors in resistance to infection: the effect of cortisone on the pathogenesis of tuberculosis. Science 113:234-237.
33. Lurie, M. B., P. Zappasodi, and C. Tickner. 1955. On the nature of genetic resistance to tuberculosis in the light of host-parasite relationships in natively resistant and susceptible rabbits. Am. Rev. Tuberc. Pulm. Dis. 72:297-329.
34. McManus, I. C., D. N. J. Lockwood, J. L. Stanford, M. A. Shaahan, M. Abdul-Ati, and G. M. Bahr. 1988. Recognition of a category of responders to group II, slow-grower associated, antigens amongst Kuwaiti senior school children, using a statistical model. Tubercle 69:275-281.
35. McMurray, D. N., F. M. Collins, A. M. Dannenberg, Jr., and D. W. Smith. 1996. Pathogenesis of experimental tuberculosis in animal models, p. 157-179. In T. M. Shinnick (ed.) Tuberculosis. Springer-Verlag, Berlin, Germany.
36. Medzhitov, R., and C. A. Janeway, Jr. 1997. Innate immunity: impact on the adaptive immune response. Curr. Opin. Immunol. 9:4-9.
37. Mosmann, T. R., and S. Sad. 1996. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 17:138-146.
38. National Research Council. 1985. Guide for the care and use of laboratory animals. National Institutes of Health publication 86-23. National Institutes of Health, Bethesda, Md.
39. Onyebujoh, P., T. Abdulmumini, S. Robinson, G. A. W. Rook, and J. L. Stanford. 1995. Immunotherapy with Mycobacterium vaccae as an addition to chemotherapy for the treatment of pulmonary tuberculosis under difficult conditions in Africa. Respir. Med. 89:199-207.
40. Romagnani, S. 1997. The Th1/Th2 paradigm. Immunol. Today 18:263-266.
41. + T cells in chronic infections: an immunoendocrinological hypothesis not exclusive to HIV. Immunol. Today 14:568-569.
42. Rook, G. A. W., and R. al Attiyah. 1991. Cytokines and the Koch phenomenon. Tubercle 72:13-20.
43. Rook, G. A. W., G. M. Bahr, and J. L. Stanford. 1981. The effect of two distinct forms of cell-mediated response to mycobacteria on the protective efficacy of BCG. Tubercle 62:63-68.
44. Rook, G. A. W., and B. R. Bloom. 1994. Mechanisms of pathogenesis in tuberculosis, p. 485-501. In B. R. Bloom (ed.), Tuberculosis: pathogenesis, protection, and control. American Society for Microbiology, Washington, D.C.
45. Rook, G. A. W., and R. Hernandez-Pando. 1994. T cell helper types and endocrines in the regulation of tissue-damaging mechanisms in tuberculosis. Immunobiology 191:478-492.
46. Rook, G. A. W., and R. Hernandez-Pando. 1996. The pathogenesis of tuberculosis. Annu. Rev. Microbiol. 50:259-284.
47. Rosner, B. 1995. Fundamentals of biostatistics, 4th ed., p. 443-550. Wadsworth Publishing Co., Belmont, Calif.
48. Shield, M. J. 1983. The importance of immunologically effective contact with environmental mycobacteria, p. 343-415. In C. Ratledge and J. L. Stanford (ed.), The biology of mycobacteria, vol. 2. Academic Press, London, United Kingdom.
49. Stanford, J. L. 1997. Newer tuberculins: profile in developing countries, p. 58-72. In V. Seth (ed.), Essentials of tuberculosis in children. Jaypee Brothers, New Delhi, India.
50. Stanford, J. L., and J. M. Grange. 1974. The meaning and structure of speeies as applied to mycobacteria. Tubercle 55:143-152.
51. Stanford, J. L., and J. M. Grange. 1993. New concepts for the control of tuberculosis in the twenty-first century. J. R. Coll. Physicians Lond. 27:218-223.
52. Stanford, J. L., G. A. W. Rook, G. M. Bahr, Y. Dowlati, R. Ganapati, K. Ghazi-Saidi, S. Lucas, G. Ramu, P. Torres, H. Minh-Ly, and N. Anstey. 1990. Mycobacterium vaccae in immunoprophylaxis and immunotherapy of leprosy and tuberculosis. Vaccine 8:525-530.
53. Stanford, J. L., and C. A. Stanford. 1996. Immunotherapy with Mycobacterium vaccae and the treatment of tuberculosis. J. Appl. Bacteriol. 81:81S-86S.
54. Stanford, J. L., C. A. Stanford, G. A. W. Rook, and J. M. Grange. 1994. Immunotherapy for tuberculosis: investigative and practical aspects. Clin. Immunother. 1:430-440.
55. Tsukamura, M. 1984. The "non-pathogenic" species of mycobacteria: their distribution and ecology in non-living reservoirs, p. 1339-1359. In G. P. Kubicka and L. G. Wayne (ed.), The mycobacteria: a sourcebook, vol. 15. Marcel Dekker, New York, N.Y.
56. Tsuyuguchi, I. 1996. Regulation of the human response in tuberculosis. Infect. Agents Dis. 5:82-97.
57. von Reyn, C. F., R. D. Arbeit, G. Yeaman, R. D. Waddell, B. J. Marsh, P. Morin, J. F. Modlin, and H. G. Remold. 1997. Immunization of healthy adult subjects in the United States with inactivated Mycobacterium vaccae administered in a three-dose series. Clin. Infect. Dis. 24:843-848.
58. Wiegeshaus, E. H., D. N. McMurray, A. A. Grover, G. E. Harding, and D. W. Smith. 1970. Host-parasite relationships in experimental airborne tuberculosis. III. Relevance of microbial enumeration to acquired resistance in guinea pigs. Am. Rev. Respir. Dis. 102:422-429.
59. Woolson, R. F. 1987. Statistical methods for the analysis of biomedical data, p. 280-313. John Wiley and Sons, New York, N.Y.
60. Yamamura, Y. 1958. The pathogenesis of tuberculous cavities. Adv. Tuberc. Res. 9:13-37.
61. Yamamura, Y., Y. Ogawa, H. Maeda, and Y. Yamamura. 1974. Prevention of tuberculosis cavity formation by desensitization with tuberculin-active peptide. Am. Rev. Respir. Dis. 109:594-601.